Relative strength leaders in Healthcare

    Largest excess return over the S&P 500 across three months, narrowed to healthcare names Autonium covers.

    Market data as of 2026-10-26

    The short answer

    16 covered healthcare names qualify. MRNA (Moderna Inc.) leads on 3-month excess return, with market data as of 2026-10-26.

    #Name3-month excess returnAlgo ScoreTrend
    1MRNA Moderna Inc.+253.0%47Uptrend
    2NVAX Novavax Inc.+24.2%14Range
    3ISRG Intuitive Surgical+21.5%—Range
    4TMO Thermo Fisher Scientific+15.5%—Uptrend
    5PFE Pfizer Inc.+14.7%—Uptrend
    6DHR Danaher Corp.+13.7%—Uptrend
    7ABBV AbbVie Inc.+5.6%—Uptrend
    8MRK Merck & Co.+3.4%—Range
    9VRTX Vertex Pharmaceuticals+2.2%—Range
    10CLOV Clover Health Investments+1.9%50Uptrend
    11LLY Eli Lilly and Co.+1.5%—Uptrend
    12JNJ Johnson & Johnson-3.5%—Uptrend
    13BSX Boston Scientific-4.4%—Range
    14ABT Abbott Laboratories-5.5%—Range
    15UNH UnitedHealth Group-7.5%—Uptrend
    16SYK Stryker Corp.-15.0%—Range

    Track the healthcare names that matter

    Autonium breaks each score into its factors and tells you when the read changes.

    Type a ticker

    Other healthcare rankings

    Highest Algo ScoresMomentum leadersMost volatile namesAlgo Score gainersAlgo Score declinersOverbought namesOversold namesDeepest drawdowns
    relative strength across the whole covered market

    Autonium publishes research, not recommendations. Scores, factors and written reads describe historical and current data and are not buy or sell advice. Not financial advice. Market data is refreshed on a schedule and may lag. See our methodology and disclosures.